Hyaluronan-CD44 interactions as potential targets for cancer therapy.
about
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinomaRole of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightThe role of CD44 in epithelial-mesenchymal transition and cancer developmentDrug Carrier for Photodynamic Cancer TherapyRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryExtracellular matrix macromolecules: potential tools and targets in cancer gene therapyModulation of the tumor microenvironment for cancer treatment: a biomaterials approachInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerGlycoproteins and glycoproteomics in pancreatic cancerHyaluronan - a functional and structural sweet spot in the tissue microenvironmentSynergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cellsCD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding SiteCD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells.Biochemical and biological characterization of exosomes containing prominin-1/CD133.CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Brain metastasis-initiating cells: survival of the fittest.Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerHyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in AtherosclerosisCD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomasCD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapyAnalysis of cell adhesion during early stages of colon cancer based on an extended multi-valued logic approach.Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds.Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.Spatio-temporal patterns of pancreatic cancer cells expressing CD44 isoforms on supported membranes displaying hyaluronic acid oligomers arrays.Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasionRASSF6 expression in adipocytes is down-regulated by interaction with macrophages.Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosomeCisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding.Polysaccharide-Coated Magnetic Nanoparticles for Imaging and Gene Therapy.Hyaluronan regulation of endothelial barrier function in cancer.Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
P2860
Q26752400-5A06B0B8-F94E-4AF9-AE3E-BCF2604793FEQ26766075-6FD12D6F-862E-419E-BB9E-5EC9C81CA44BQ26771509-8DE434C4-374C-4C47-9E91-D51ABD32BE9DQ26782780-21EE307F-48FB-4560-B3DA-A8B2BB8B8D75Q26786042-78CFE677-AC56-4299-BCAD-E9BEBFFCF7D5Q26786070-2260984E-EFC3-4E92-8C0B-524636B134FEQ26996081-5952B3A1-2359-4FE9-A77C-4A514008AEB5Q26996790-FF421955-0BFF-4CB4-AF64-68123B130E75Q27021261-3350D07A-C88C-48CC-97E9-24698B2F1194Q28071108-E47E6189-6CC5-4BB9-9BF7-567FB8D508F5Q28081088-FF0C3476-975B-43C2-9FBE-39A0B8333FD9Q28485464-7464D749-EE10-40F3-BCB4-ECCF6845302DQ28548190-ABCDA485-585E-4932-853A-A861B4F454E4Q30407458-599251B7-8FED-4F22-9D9A-013285EC079FQ30541069-9C9B55D4-B160-47D4-ACE3-D50FDA30799FQ33556551-90A6561C-A2DF-414E-B30D-790B8ECB0DF5Q33613734-D1B6D75F-DC01-4ACA-A661-EA31F3232909Q33648449-DEC22F96-3245-4CED-A980-1A28F60C5729Q33755959-5FB4E37F-5B30-4E43-84B0-8F4825D55F8DQ33811463-303DEB9C-E6FE-4645-B7C2-5C3041DD2D52Q33855839-7194D3AC-3CBD-48E2-8DCD-B90FA34B7F67Q33856678-21D4561D-70F6-43F2-85D8-E1D928F97C9EQ33890100-D7B33E08-53A8-4235-BAF8-325DB9A5EACFQ33972081-31350F8E-30D7-4B64-9A7A-B6308EA3A3D2Q33993634-862FCE7B-EF28-4C23-9583-5600BE891343Q34148743-47784BAC-3323-4352-A524-47D96CC7E47BQ34205351-171BA9D7-2B7E-4EDE-906E-8836FA3FCE46Q34232877-DC9BD4B6-6E81-46FD-BC8B-0C8C0C35ED71Q34391180-47DABA14-4341-4446-9506-D761EBEF815FQ34502070-71CF694D-F9CE-4A2C-BB0C-C3B0DAD8D66BQ34598261-1698F8CE-15B5-41F8-98AC-5F81CE85D7EBQ34692553-BCFB4AA4-AB39-43B3-85EF-BDE6622CEC01Q35023463-D82D9F07-6B75-415A-90DF-09A71C511C83Q35177969-2417BFB3-25D3-4A1F-A5AF-E8228EDF8A86Q35292720-843A4E18-960A-46F0-9B54-C803AE50D1BDQ35638440-A6CF42B0-19D7-489C-B578-991B9836B8FDQ35674709-6B69DC91-1D6D-4C50-B8EF-617D2BB9379FQ35751329-EE6C7095-0B74-4C34-8924-3C1D679F3CADQ35794084-E9A11889-1E38-4368-BD11-0C4A88A836F9Q35802940-1AF98FBF-8134-4480-9488-A683E59DE972
P2860
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@ast
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@en
type
label
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@ast
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@en
prefLabel
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@ast
Hyaluronan-CD44 interactions as potential targets for cancer therapy.
@en
P2093
P2860
P1433
P1476
Hyaluronan-CD44 interactions as potential targets for cancer therapy
@en
P2093
Paraskevi Heldin
Roger R Markwald
Shibnath Ghatak
Spyros S Skandalis
Suniti Misra
Vincent C Hascall
P2860
P304
P356
10.1111/J.1742-4658.2011.08071.X
P407
P577
2011-03-25T00:00:00Z